| NCBP2 |
NCBP2, CBP20, PIG55: Nuclear cap-binding protein subunit 2 |
KPNB1 |
KPNB1, NTF97: Importin subunit beta-1 |
47.4 |
Evidence |
O
|
| PDGFRA |
PDGFRA: Alpha-type platelet-derived growth factor receptor precursor |
STAT6 |
STAT6: Signal transducer and activator of transcription 6 |
47.370 |
Evidence |
|
| EPHB3 |
EPHB3, ETK2, HEK2, TYRO6: Ephrin type-B receptor 3 precursor |
BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
47.370 |
Evidence |
|
| EPHB2 |
EPHB2, DRT, EPHT3, EPTH3, ERK, HEK5, TYRO5: Ephrin type-B receptor 2 precursor |
CSK |
CSK: Tyrosine-protein kinase CSK |
47.370 |
Evidence |
|
| EPHB3 |
EPHB3, ETK2, HEK2, TYRO6: Ephrin type-B receptor 3 precursor |
LYN |
LYN: Tyrosine-protein kinase Lyn |
47.370 |
Evidence |
|
| ERBB2 |
ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor |
SYK |
SYK: Tyrosine-protein kinase SYK |
47.370 |
Evidence |
|
| EPHB2 |
EPHB2, DRT, EPHT3, EPTH3, ERK, HEK5, TYRO5: Ephrin type-B receptor 2 precursor |
ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
47.370 |
Evidence |
|
| INSR |
INSR: Insulin receptor precursor |
CSK |
CSK: Tyrosine-protein kinase CSK |
47.370 |
Evidence |
|
| EPHB2 |
EPHB2, DRT, EPHT3, EPTH3, ERK, HEK5, TYRO5: Ephrin type-B receptor 2 precursor |
SYK |
SYK: Tyrosine-protein kinase SYK |
47.370 |
Evidence |
|
| FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
EPHB3 |
EPHB3, ETK2, HEK2, TYRO6: Ephrin type-B receptor 3 precursor |
47.370 |
Evidence |
|
| ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
EPHB1 |
EPHT2, EPHB1, NET: Ephrin type-B receptor 1 precursor |
47.370 |
Evidence |
|
| PLK4 |
PLK4, SAK, STK18: Serine/threonine-protein kinase PLK4 |
MCM2 |
MCM2, BM28, CCNL1, CDCL1, KIAA0030: DNA replication licensing factor MCM2 |
47.320 |
Evidence |
|
| PLK4 |
PLK4, SAK, STK18: Serine/threonine-protein kinase PLK4 |
MCM3 |
MCM3: DNA replication licensing factor MCM3 |
47.320 |
Evidence |
|
| PRKCI |
PRKCI, DXS1179E: Protein kinase C iota type |
WWC2 |
WW and C2 domain containing 2 |
47.290 |
Evidence |
|
| SMAD3 |
SMAD3, MADH3: Mothers against decapentaplegic homolog 3 |
MTF1 |
MTF1: Metal regulatory transcription factor 1 |
47.290 |
Evidence |
|
| MET |
MET: Hepatocyte growth factor receptor precursor |
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
47.270 |
Evidence |
|
| CSK |
CSK: Tyrosine-protein kinase CSK |
TEK |
TEK, TIE2: Angiopoietin-1 receptor precursor |
47.270 |
Evidence |
|
| F10 |
F10: Coagulation factor X precursor |
MGMT |
MGMT: Methylated-DNA--protein-cysteine methyltransferase |
47.110 |
Evidence |
|
| STAT6 |
STAT6: Signal transducer and activator of transcription 6 |
IRF3 |
IRF3: Interferon regulatory factor 3 |
47.110 |
Evidence |
|
| TP53 |
TP53, P53: Cellular tumor antigen p53 |
MCM3 |
MCM3: DNA replication licensing factor MCM3 |
46.930 |
Evidence |
|
| SFRS10 |
SFRS10, TRA2B: Splicing factor, arginine/serine-rich 10 |
PIP5K3 |
PIP5K3, KIAA0981, PIKFYVE: FYVE finger-containing phosphoinositide kinase |
46.930 |
Evidence |
|
| C1R |
C1R: Complement C1r subcomponent precursor |
HP |
HP: Haptoglobin precursor [Contains: Haptoglobin alpha chain; Haptoglobin beta c |
46.900 |
Evidence |
|
| SNRPD1 |
SNRPD1: Small nuclear ribonucleoprotein Sm D1 |
GNB2L1 |
Lung cancer oncogene 7 |
46.900 |
Evidence |
|
| SNRPB2 |
SNRPB2: U2 small nuclear ribonucleoprotein B'' |
RDBP |
RDBP, NELFE, RD: Negative elongation factor E |
46.900 |
Evidence |
|
| TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
MAP4K1 |
MAP4K1, HPK1: Mitogen-activated protein kinase kinase kinase kinase 1 |
46.900 |
Evidence |
|